
Overview
Dr. Bonifant is a pediatric oncologist on the blood and marrow transplantation team at the Sidney Kimmel Comprehensive Cancer Center and an Assistant Professor of Pediatric Oncology at the Johns Hopkins University School of Medicine. She is also a member of the Bloomberg-Kimmel Institute for Immunotherapy. Her clinical specialty is stem cell transplantation for high-risk leukemias. Her research interests are in the areas of immunotherapy of cancer and malignant hematology. Currently, her research focuses on design and development of immune therapies as a treatment for poor-prognosis cancers, including development of engineered cellular immunotherapies for the treatment of Acute Myeloid Leukemia. Dr. Bonifant is a graduate of Wake Forest University and Georgetown University. She completed her Pediatric and Hematology/Oncology training at Johns Hopkins and at Baylor College of Medicine. Prior to her appointment at Johns Hopkins, she was an Assistant Professor in Pediatrics-Hematology/Oncology at the University of Michigan.
Dr. Bonifant is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Leukemia, Acute Lymphoblastic Leukemia (ALL), Infantile Neutropenia, Childhood Acute Myeloid Leukemia, and Bone Marrow Transplant.
Dr. Bonifant is board certified in American Board Of Pediatrics. She is actively involved in clinical research, co-authoring 47 peer reviewed articles and participating in 1 clinical trial.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
Locations
1800 Orleans Street, Bloomberg 11N, Bloomberg 11N, Baltimore, MD 21287
Additional Areas of Focus
Dr. Bonifant has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Rubenstein Child Health Building
Dr. Julie Hoover-Fong is a Professor of Genetic Medicine and Pediatrics and Director of the Greenberg Center for Skeletal Dysplasias at Johns Hopkins University. Dr. Hoover-Fong holds a bachelor’s degree in Human Nutrition from The Ohio State University, where she also completed her medical degree. She received her Ph.D. in the Graduate Training Program in Clinical Investigation at the Johns Hopkins University School of Medicine and Bloomberg School of Public Health. Dr. Hoover-Fong completed a pediatric internship and residency at Washington University in St. Louis and a fellowship in medical genetics at Johns Hopkins University in Baltimore. She joined the Johns Hopkins University faculty in 2002 and progressed to Professor of Genetic Medicine and Pediatrics in 2019. She practices and oversees the clinical operations, research and educational ventures for the patients, families and healthcare providers served by the Greenberg Center. Her clinical team develops and improves diagnostic and treatment guidelines for comprehensive care of patients with all types of bone conditions including dwarfism, orofacial clefting, craniosynostosis and more. Dr. Hoover-Fong also mentors and teaches medical students, residents and genetic medicine trainees. As an active clinical researcher, Dr. Hoover-Fong is the Principal Investigator of multiple global clinical trials for achondroplasia, the first multi-center, investigator-initiated natural history study for achondroplasia, and multiple clinical studies for patients with orofacial clefting, hypophosphatasia and other conditions. She is also a co-investigator on the ELSI and Phenotype Review Committees for the Mendel Project, a whole exome sequencing venture to identify the genetic cause of Mendelian conditions. From an institutional service perspective, Dr. Hoover-Fong serves on the Johns Hopkins Associate Professor Promotions Committee and the Advisory Committee for the Graduate Training Program in Clinical Investigation. She serves on the Medical Advisory Board of the Little People of America, is a member of the Miller-Coulson Academy of Clinical Excellence at Johns Hopkins University and is a charter member of the International Skeletal Dysplasia Management Consortium, publishing best practice guidelines for patients with skeletal dysplasias. Dr. Hoover is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Achondroplasia, Rhizomelic Syndrome, Spondyloepimetaphyseal Dysplasia Strudwick Type, Adenoidectomy, and Myringotomy. Dr. Hoover is board certified in American Board Of Medical Genetics And Genomics.
Johns Hopkins Outpatient Center
Catherine Chu is the director of the Division of Pediatric Neurology and the John M. Freeman Pediatric Epilepsy Center in the Johns Hopkins Department of Neurology, as well as the vice president of child neurology at the Kennedy Krieger Institute. As a child neurologist, epileptologist and clinical neurophysiologist, Dr. Chu cares for children diagnosed with epilepsy and disorders of the nervous system (neurophysiology). She specializes in electroencephalogram (also known as EEG) analysis, seizure localization, surgical planning and neuromodulation for adult and pediatric patients with difficult to control epilepsy. She is nationally and internationally recognized for her work identifying causes of and treatment options for cognitive dysfunction and seizures in epilepsy and neurodevelopmental disorders. Dr. Chu’s team specializes in identifying and developing tools to detect and understand brain rhythms that support complex cognitive functions throughout development, including how these rhythms are disrupted by seizures and neurodevelopmental disorders. Dr. Chu earned her medical degree and a master’s degree in social anthropology from Harvard University. She completed an internship in pediatrics at Massachusetts General Hospital, and then a residency in neurology and child neurology at Massachusetts General and Brigham and Women’s Hospital. After completing two fellowships at Massachusetts General, one in epilepsy and another in clinical neurophysiology, Dr. Chu earned a master’s degree in medical science, focused on clinical investigation, from Harvard Medical School. Dr. Chu is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Benign Rolandic Epilepsy, Epilepsy in Children, Seizures, Epilepsy, and Deep Brain Stimulation. Dr. Chu is board certified in American Board Of Psychiatry And Neurology.
Nancy Braverman is a Medical Genetics specialist and a Pediatrics provider practicing medicine in Baltimore, Maryland. Dr. Braverman is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Zellweger Syndrome, Acromesomelic Dysplasia, Achondrogenesis, and Acromesomelic Dysplasia Campailla Martinelli Type.
Frequently Asked Questions about Dr. Challice L. Bonifant
How do I make an appointment with Dr. Challice L. Bonifant?
You can book an appointment with Dr. Challice L. Bonifant by calling their office at 410-955-8751. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Challice L. Bonifant a top-rated expert for Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Challice L. Bonifant is classified as an Advanced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Challice L. Bonifant specialize in?
While Dr. Challice L. Bonifant is a Pediatrics, they have specific expertise in Leukemia, Acute Lymphoblastic Leukemia (ALL), and Infantile Neutropenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatrics.
Does Dr. Challice L. Bonifant participate in research or clinical trials?
Yes. Dr. Challice L. Bonifant has published 47 articles and abstracts on conditions like Leukemia. You can view a list of Dr. Challice L. Bonifant's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Challice L. Bonifant accept my insurance?
Dr. Challice L. Bonifant accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-8751 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- LeukemiaDr. Bonifant isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Bonifant isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult T-Cell LeukemiaDr. Bonifant isExperienced. Learn about Adult T-Cell Leukemia.
- Bone Marrow TransplantDr. Bonifant isExperienced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Bonifant isExperienced. Learn about Childhood Acute Myeloid Leukemia.
- Graft Versus Host Disease (GvHD)Dr. Bonifant isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Infantile NeutropeniaDr. Bonifant isExperienced. Learn about Infantile Neutropenia.

